// App-Quantinova.ai

e14584 : A pilot study of evaluation of a phosphorylation signature from pancreatic cancer tumors.

Researchers

Presenter

  • Andrea Wang-Gillam

Principal Investigators

  • Sachin Wani

  • Dayna S Early

  • Sharat Singh

  • Phillip Sangwook Kim

  • Kian-Huat Lim

  • David Linehan

  • Riad Azar

  • Steven Alphonse Edmundowicz

  • Daniel Mullady

  • Faris Murad

  • Sreenivasa Jonnalagadda

  • Feng Gao

  • Thomas Hollander

  • Emma J. Langley

  • Gary Meyer

Medical Centers

  • National Cancer Institute, Bethesda, MD

  • Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO

  • Washington University School of Medicine, St. Louis, MO

  • Washington University, St Louis, MO

  • University of Colorado Anschutz Medical Campus, Aurora, CO

  • Washington University in St Louis, St. Louis, MO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

Biomarkers

  • Circulating tumor cells

  • Epidermal growth factor receptor

  • erb-b2 receptor tyrosine kinase 2

  • Erb-B2 Receptor Tyrosine Kinase 3

  • Extracellular signal-regulated kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved